{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:58:05Z","timestamp":1793609885653,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>A considerable proportion of patients hospitalized with coronavirus disease 2019 (COVID-19) acquired secondary bacterial infections (SBIs). The etiology and antimicrobial resistance of bacteria were reported and used to provide a theoretical basis for appropriate infection therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study reviewed electronic medical records of all the patients hospitalized with COVID-19 in the Wuhan Union Hospital between January 27 and March 17, 2020. According to the inclusion and exclusion criteria, patients who acquired SBIs were enrolled. Demographic, clinical course, etiology, and antimicrobial resistance data of the SBIs were collected. Outcomes were also compared between patients who were classified as severe and critical on admission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 1495 patients hospitalized with COVID-19, 102 (6.8%) patients had acquired SBIs, and almost half of them (49.0%, 50\/102) died during hospitalization. Compared with severe patients, critical patients had a higher chance of SBIs. Among the 159 strains of bacteria isolated from the SBIs, 136 strains (85.5%) were Gram-negative bacteria. The top three bacteria of SBIs were\n                      <jats:italic>A. baumannii<\/jats:italic>\n                      (35.8%, 57\/159),\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      (30.8%, 49\/159), and\n                      <jats:italic>S. maltophilia<\/jats:italic>\n                      (6.3%, 10\/159). The isolation rates of carbapenem-resistant\n                      <jats:italic>A. baumannii<\/jats:italic>\n                      and\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      were 91.2 and 75.5%, respectively. Meticillin resistance was present in 100% of\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      and\n                      <jats:italic>Coagulase negative staphylococci<\/jats:italic>\n                      , and vancomycin resistance was not found.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      SBIs may occur in patients hospitalized with COVID-19 and lead to high mortality. The incidence of SBIs was associated with the severity of illness on admission. Gram-negative bacteria, especially\n                      <jats:italic>A. baumannii<\/jats:italic>\n                      and\n                      <jats:italic>K. pneumoniae,<\/jats:italic>\n                      were the main bacteria, and the resistance rates of the major isolated bacteria were generally high. This was a single-center study; thus, our results should be externally examined when applied in other institutions.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13756-020-00819-1","type":"journal-article","created":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T11:34:28Z","timestamp":1601638468000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":171,"title":["Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis"],"prefix":"10.1186","volume":"9","author":[{"given":"Jie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peishan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingchao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,22]]},"reference":[{"key":"819_CR1","unstructured":"World Health Organization. WHO Coronavirus disease (COVID-2019) dashboard. Available at: https:\/\/covid19.who.int\/. Accessed 21 July 2020."},{"issue":"10223","key":"819_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506.","journal-title":"Lancet"},{"issue":"10229","key":"819_CR3","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362.","journal-title":"Lancet."},{"key":"819_CR4","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3389\/fmicb.2017.01041","volume":"8","author":"DE Morris","year":"2017","unstructured":"Morris DE, Cleary DW, Clarke SC. Secondary bacterial infections associated with influenza pandemics. Front Microbiol. 2017;8:1041.","journal-title":"Front Microbiol"},{"issue":"6","key":"819_CR5","doi-asserted-by":"publisher","first-page":"e440","DOI":"10.1097\/CCM.0000000000004363","volume":"48","author":"W Alhazzani","year":"2020","unstructured":"Alhazzani W, Moller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Crit Care Med. 2020;48(6):e440\u201369.","journal-title":"Crit Care Med"},{"issue":"1","key":"819_CR6","first-page":"4","volume":"7","author":"YH Jin","year":"2020","unstructured":"Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020;7(1):4.","journal-title":"Mil Med Res"},{"issue":"2","key":"819_CR7","first-page":"129","volume":"32","author":"Chinese Research Hospital Association of Critical Care Medicine, Youth Committee of Chinese Research Hospital Association of Critical Care Medicine","year":"2020","unstructured":"Chinese Research Hospital Association of Critical Care Medicine, Youth Committee of Chinese Research Hospital Association of Critical Care Medicine. Chinese experts consensus on diagnosis and treatment of severe and critical new coronavirus pneumonia. Chin Crit Care Med. 2020;32(2):129\u201334.","journal-title":"Chin Crit Care Med"},{"issue":"15","key":"819_CR8","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/cid\/ciaa272","volume":"71","author":"Z Wang","year":"2020","unstructured":"Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2020;71(15):769\u201377.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"819_CR9","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1473-3099(20)30176-6","volume":"20","author":"N Yu","year":"2020","unstructured":"Yu N, Li W, Kang Q, Xiong Z, Wang S, Lin X, et al. Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-Centre, descriptive study. Lancet Infect Dis. 2020;20(5):559\u201364.","journal-title":"Lancet Infect Dis"},{"issue":"10223","key":"819_CR10","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507\u201313.","journal-title":"Lancet."},{"issue":"7","key":"819_CR11","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1111\/all.14289","volume":"75","author":"X Dong","year":"2020","unstructured":"Dong X, Cao YY, Lu XX, Zhang JJ, Du H, Yan YQ, et al. Eleven faces of coronavirus disease 2019. Allergy. 2020;75(7):1699\u2013709.","journal-title":"Allergy."},{"issue":"24","key":"819_CR12","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1056\/NEJMc2010419","volume":"382","author":"P Goyal","year":"2020","unstructured":"Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical characteristics of covid-19 in New York City. N Engl J Med. 2020;382(24):2372\u20134.","journal-title":"N Engl J Med"},{"issue":"5","key":"819_CR13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","volume":"36","author":"TC Horan","year":"2008","unstructured":"Horan TC, Andrus M, Dudeck MA. CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309\u201332.","journal-title":"Am J Infect Control"},{"key":"819_CR14","unstructured":"National Health Commission of the People\u2019s Republic of China. New coronavirus pneumonia prevention and control program (7th ed) (in Chinese). Available at: http:\/\/www.gov.cn\/zhengce\/zhengceku\/2020-03\/04\/5486705\/files\/ae61004f930d47598711a0d4cbf874a9.pdf. Accessed 28 Aug 2020."},{"key":"819_CR15","volume-title":"Performance standards for antimicrobial susceptibility testing: twenty-ninth informational supplement (M100-S29)","author":"Clinical and Laboratory Standard Institute","year":"2019","unstructured":"Clinical and Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing: twenty-ninth informational supplement (M100-S29). Wayne: Clinical and Laboratory Standard Institute; 2019."},{"key":"819_CR16","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijid.2020.03.053","volume":"94","author":"X Li","year":"2020","unstructured":"Li X, Wang L, Yan S, Yang F, Xiang L, Zhu J, et al. Clinical characteristics of 25 death cases with COVID-19: a retrospective review of medical records in a single medical center, Wuhan, China. Int J Infect Dis. 2020;94:128\u201332.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"819_CR17","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/pubmed\/fdv042","volume":"38","author":"B Guzman-Herrador","year":"2016","unstructured":"Guzman-Herrador B, Molina CD, Allam MF, Navajas RF. Independent risk factors associated with hospital-acquired pneumonia in an adult ICU: 4-year prospective cohort study in a university reference hospital. J Public Health (Oxf). 2016;38(2):378\u201383.","journal-title":"J Public Health (Oxf)"},{"issue":"1","key":"819_CR18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jaci.2020.04.006","volume":"146","author":"X Li","year":"2020","unstructured":"Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110\u20138.","journal-title":"J Allergy Clin Immunol"},{"issue":"15","key":"819_CR19","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/cid\/ciaa248","volume":"71","author":"C Qin","year":"2020","unstructured":"Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020;71(15):762\u20138.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 4","key":"819_CR20","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1016\/j.ajic.2007.05.011","volume":"36","author":"R Chawla","year":"2008","unstructured":"Chawla R. Epidemiology, etiology, and diagnosis of hospital-acquired pneumonia and ventilator-associated pneumonia in Asian countries. Am J Infect Control. 2008;36(Suppl 4):S93\u2013100.","journal-title":"Am J Infect Control"},{"issue":"Suppl 1","key":"819_CR21","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1086\/653053","volume":"51","author":"RN Jones","year":"2010","unstructured":"Jones RN. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis. 2010;51(Suppl 1):S81\u20137.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 7","key":"819_CR22","doi-asserted-by":"publisher","first-page":"S565","DOI":"10.1093\/cid\/ciz830","volume":"69","author":"Y Doi","year":"2019","unstructured":"Doi Y. Treatment options for carbapenem-resistant gram-negative bacterial infections. Clin Infect Dis. 2019;69(Suppl 7):S565\u201375.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"819_CR23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S1473-3099(17)30747-8","volume":"18","author":"A Torres","year":"2018","unstructured":"Torres A, Zhong N, Pachl J, Timsit JF, Kollef M, Chen Z, et al. Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial. Lancet Infect Dis. 2018;18(3):285\u201395.","journal-title":"Lancet Infect Dis"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-020-00819-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-020-00819-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-020-00819-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T20:07:36Z","timestamp":1632254856000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-020-00819-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,22]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["819"],"URL":"https:\/\/doi.org\/10.1186\/s13756-020-00819-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-47870\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-47870\/v2","asserted-by":"object"}]},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,22]]},"assertion":[{"value":"22 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (Permission number: [2020]0104).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The researchers have the full right to publish the findings.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We declare that we have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"153"}}